Effects of treatment with cyclosporine, FK 506, rapamycin, mycophenolic acid, or deoxyspergualin on vascular muscle proliferation in vitro and in vivo.
Gregory
C R
CR
Department of Cardiothoracic Surgery, Stanford University School of Medicine, California.
Pratt
R E
RE
Huie
P
P
Shorthouse
R
R
Dzau
V J
VJ
Billingham
M E
ME
Morris
R E
RE
D000818:Animals; D001011:Aorta / Q000166:cytology / Q000187:drug effects; D002339:Carotid Arteries / Q000166:cytology / Q000187:drug effects*; D020212:Carotid Artery Injuries; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D016572:Cyclosporine / Q000494:pharmacology; D006146:Guanidines / Q000494:pharmacology; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000187:drug effects* / Q000293:injuries; D009173:Mycophenolic Acid / Q000494:pharmacology; D011090:Polyenes / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D020123:Sirolimus; D016559:Tacrolimus / Q000494:pharmacology
D006146:Guanidines; D007166:Immunosuppressive Agents; D011090:Polyenes; D016572:Cyclosporine; D009173:Mycophenolic Acid; C037258:gusperimus; D020123:Sirolimus; D016559:Tacrolimus